CELF1 and cancer: Given our data that SSO55 can effectively and specifically block CUG-BP1 from binding to the hypoxia response element in the IR pre-mRNA and modulate the alternative splicing pattern of IR, and considering the relevance of the IR signaling pathway in cancer, it is important to check whether these splicing changes are also functionally pertinent.